Accueil / Formation Recherche / Publications / Publications Angoiedèmes à kinines

Publications Angoiedèmes à kinines

Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.

Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.

Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: Three additional French families. 

Hereditary Angioedema, Clinical Presentation and Socio-Economic Cost of 200 French Patients. 

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.


Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight : findings from the Icatibant Outcome Survey, a cohort observational study. Caballero T et al. Clin Transl Allergy. 2018 Mar 23.
 
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial. Javaud N et al. Ann Emerg Med. 2018 Mar.
 
Icatibant for ACE-inhibitor angioedema, an opportunity to treat the patients ? Javaud N et al. J Allergy Clin Immunol Pract. 2017 Nov - Dec.

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey. Aberer W et al. Allergy Asthma Clin Immunol. 2017 Jul 5;13:3.

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. Caballero T et al. J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1214-1222.

Normal PAI-2 level in French FXII-HAE patients. Marlu R et al. J Allergy Clin Immunol. 2017 May;139(5):1719-1720.

Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort. Bouillet L et al. Eur J Dermatol. 2017 Apr 1;27(2):155-159.

ACTUALITÉS

Le Pr Eric Oksenhendler récompensé "Médecin de l'année 2018" pour son travail sur la maladie de Castleman

Le congrès des Rencontres RARE revient pour sa 6ème édition, les 5 & 6 novembre 2019
Cité des Sciences et de l'Industrie, Paris
Ouverture des candidatures pour l'ASH 2019 à Orlando
La filière MaRIH recherche deux internes "reporters" pour participer à l'ASH !
Voir toutes les actualités

AGENDA

Du 27-09-2019 au 29-09-2019 : 16èmes Journées de l’Association des Internes en Hématologie, Lyon


04-10-2019 : 7ème Journée régionale interactive maladies rares immuno-hématologiques MaRIH "Océan Indien", Saint-Denis (La Réunion)


04-10-2019 : Journée annuelle du centre de référence des aplasies médullaires acquises et constitutionnelles, Paris
Voir tout l'agenda